Sequent Scientific Ltd
Sequent Scientific is mainly engaged in the business of pharmaceuticals.
- Market Cap ₹ 6,030 Cr.
- Current Price ₹ 243
- High / Low ₹ 265 / 51.7
- Stock P/E 58.8
- Book Value ₹ 30.1
- Dividend Yield 0.00 %
- ROCE 12.3 %
- ROE 9.61 %
- Face Value ₹ 2.00
Pros
- Company has delivered good profit growth of 168.14% CAGR over last 5 years
Cons
- Stock is trading at 8.06 times its book value
- Promoter holding has decreased by -1.07% over last quarter
Peer comparison
Sector: Pharmaceuticals Industry: Pharmaceuticals - Indian - Bulk Drugs
Quarterly Results
Consolidated Figures in Rs. Crores / View Standalone
Mar 2018 | Jun 2018 | Sep 2018 | Dec 2018 | Mar 2019 | Jun 2019 | Sep 2019 | Dec 2019 | Mar 2020 | Jun 2020 | Sep 2020 | Dec 2020 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
233 | 235 | 252 | 271 | 282 | 278 | 284 | 316 | 301 | 310 | 346 | 358 | |
213 | 213 | 224 | 235 | 243 | 240 | 247 | 266 | 256 | 259 | 290 | 292 | |
Operating Profit | 19 | 23 | 28 | 36 | 39 | 38 | 37 | 50 | 45 | 51 | 56 | 66 |
OPM % | 8% | 10% | 11% | 13% | 14% | 14% | 13% | 16% | 15% | 16% | 16% | 19% |
Other Income | 408 | 2 | 2 | 2 | 2 | 1 | 6 | 1 | 2 | 2 | -6 | 3 |
Interest | 10 | 8 | 8 | 8 | 9 | 9 | 8 | 10 | 9 | 8 | 7 | 6 |
Depreciation | 9 | 10 | 10 | 11 | 11 | 12 | 12 | 13 | 13 | 13 | 13 | 12 |
Profit before tax | 409 | 7 | 12 | 18 | 22 | 19 | 23 | 28 | 24 | 32 | 29 | 51 |
Tax % | 1% | 35% | -27% | 14% | 1% | 19% | -7% | 15% | 24% | 23% | 27% | 23% |
Net Profit | 400 | 3 | 15 | 13 | 17 | 11 | 21 | 20 | 17 | 21 | 21 | 37 |
EPS in Rs | 16.40 | 0.13 | 0.62 | 0.53 | 0.69 | 0.46 | 0.86 | 0.82 | 0.68 | 0.84 | 0.86 | 1.50 |
Notes | Notes | Notes | Notes | Notes | Notes | Notes | Notes | Notes | Notes | Notes | Notes |
Profit & Loss
Consolidated Figures in Rs. Crores / View Standalone
Mar 2009 | Mar 2010 | Mar 2011 | Mar 2012 | Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | TTM | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
144 | 284 | 312 | 346 | 327 | 395 | 443 | 606 | 684 | 848 | 1,039 | 1,179 | 1,315 | |
152 | 239 | 268 | 309 | 340 | 389 | 426 | 551 | 641 | 773 | 914 | 1,009 | 1,097 | |
Operating Profit | -8 | 45 | 44 | 37 | -13 | 6 | 17 | 55 | 43 | 75 | 125 | 170 | 218 |
OPM % | -5% | 16% | 14% | 11% | -4% | 2% | 4% | 9% | 6% | 9% | 12% | 14% | 17% |
Other Income | 7 | 30 | 2 | 10 | 3 | -54 | 50 | 15 | 9 | 444 | 9 | 10 | -0 |
Interest | 5 | 22 | 24 | 30 | 33 | 34 | 43 | 38 | 28 | 33 | 33 | 36 | 31 |
Depreciation | 6 | 14 | 19 | 23 | 29 | 29 | 32 | 46 | 40 | 41 | 42 | 51 | 51 |
Profit before tax | -13 | 39 | 3 | -5 | -73 | -110 | -8 | -14 | -17 | 444 | 59 | 94 | 137 |
Tax % | -16% | 22% | 215% | 73% | 11% | -1% | -40% | -19% | 3% | 3% | 3% | 13% | |
Net Profit | -15 | 37 | -0 | -1 | -65 | -110 | -11 | -18 | -14 | 422 | 49 | 70 | 96 |
EPS in Rs | -2.64 | 3.53 | -0.02 | -0.13 | -5.39 | -8.09 | -0.70 | -0.78 | -0.57 | 17.30 | 1.97 | 2.81 | 3.88 |
Dividend Payout % | -8% | 11% | -1,770% | 0% | 0% | 0% | 0% | 0% | 0% | 1% | 10% | 0% |
Compounded Sales Growth | |
---|---|
10 Years: | 15% |
5 Years: | 22% |
3 Years: | 20% |
TTM: | 13% |
Compounded Profit Growth | |
---|---|
10 Years: | 12% |
5 Years: | 168% |
3 Years: | 96% |
TTM: | 46% |
Stock Price CAGR | |
---|---|
10 Years: | 34% |
5 Years: | 9% |
3 Years: | 46% |
1 Year: | 191% |
Return on Equity | |
---|---|
10 Years: | 9% |
5 Years: | 14% |
3 Years: | 24% |
Last Year: | 10% |
Balance Sheet
Consolidated Figures in Rs. Crores / View Standalone
Mar 2009 | Mar 2010 | Mar 2011 | Mar 2012 | Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Sep 2020 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
11 | 21 | 21 | 21 | 23 | 27 | 30 | 48 | 49 | 49 | 49 | 50 | 50 | |
Reserves | 29 | 91 | 102 | 101 | 60 | 1 | 32 | 885 | 928 | 599 | 657 | 693 | 699 |
Borrowings | 97 | 175 | 189 | 269 | 311 | 418 | 473 | 312 | 416 | 305 | 325 | 331 | 261 |
118 | 95 | 126 | 156 | 192 | 177 | 372 | 278 | 503 | 380 | 346 | 437 | 593 | |
Total Liabilities | 256 | 382 | 439 | 547 | 586 | 623 | 908 | 1,523 | 1,896 | 1,332 | 1,378 | 1,510 | 1,602 |
107 | 185 | 211 | 230 | 227 | 238 | 474 | 586 | 684 | 476 | 498 | 632 | 594 | |
CWIP | 16 | 24 | 20 | 64 | 89 | 43 | 39 | 24 | 33 | 18 | 23 | 13 | 17 |
Investments | 15 | 1 | 0 | 0 | 2 | 0 | 59 | 428 | 428 | 239 | 180 | 171 | 231 |
117 | 173 | 208 | 253 | 268 | 342 | 336 | 485 | 751 | 599 | 677 | 693 | 760 | |
Total Assets | 256 | 382 | 439 | 547 | 586 | 623 | 908 | 1,523 | 1,896 | 1,332 | 1,378 | 1,510 | 1,602 |
Cash Flows
Consolidated Figures in Rs. Crores / View Standalone
Mar 2009 | Mar 2010 | Mar 2011 | Mar 2012 | Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
-5 | 17 | 50 | 21 | -4 | -45 | -24 | -0 | -7 | 45 | 116 | 115 | |
-29 | -1 | -71 | -65 | -55 | -81 | -157 | -310 | -116 | 7 | -68 | -72 | |
34 | -6 | 17 | 62 | 35 | 146 | 179 | 309 | 147 | -57 | -20 | -43 | |
Net Cash Flow | -0 | 10 | -5 | 18 | -24 | 20 | -1 | -2 | 24 | -5 | 28 | 0 |
Ratios
Consolidated Figures in Rs. Crores / View Standalone
Mar 2009 | Mar 2010 | Mar 2011 | Mar 2012 | Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
ROCE % | -7% | 20% | 11% | 5% | -10% | -4% | 10% | 3% | 1% | 41% | 9% | 12% |
Debtor Days | 100 | 71 | 65 | 74 | 73 | 77 | 95 | 116 | 136 | 111 | 98 | 99 |
Inventory Turnover | 3.56 | 3.22 | 2.93 | 3.17 | 2.65 | 2.50 | 2.54 | 2.84 | 2.50 | 2.99 | 3.16 | 3.00 |
Documents
Add documentRecent announcements
- Intimation Under Regulation 30 Of The Securities And Exchange Board Of India (Listing Obligations & Disclosure Requirements) Regulations, 2015 - Grant Of Stock Options To Eligible Employees Of The Company And Its Subsidiaries Under ''Sequent Scientific Employee Stock Option Plan 2020'' 1 Mar
- Announcement under Regulation 30 (LODR)-Newspaper Publication 14 Feb
- Shareholder Meeting / Postal Ballot-Notice of Postal Ballot 12 Feb
- Announcement under Regulation 30 (LODR)-Newspaper Publication 5 Feb
- Announcement under Regulation 30 (LODR)-Press Release / Media Release (Revised) 3 Feb
View all
Annual reports
- Financial Year 2020 from bse
- Financial Year 2019 from bse
- Financial Year 2018 from bse
- Financial Year 2017 from bse
- Financial Year 2016 from bse
- Financial Year 2015 from bse
- Financial Year 2014 from bse
- Financial Year 2013 from bse
- Financial Year 2012 from bse
- Financial Year 2011 from bse
- Financial Year 2010 from bse